Production Featured Articles

  1. Small Molecule Pharma Companies Are Employing These Advanced Technologies To Get Ahead 5/19/2025

    Small molecule drug companies are employing these concrete innovations, including several associated with Pharma 4.0, all boosting quality and efficiency.

  2. Solutions For Mitigating Challenges In Recombinant Protein Production 5/13/2025

    Through the use of advanced mitigation strategies, we optimize yield, enhance protein quality, and ensure functional integrity, helping clients achieve efficient and reliable recombinant protein production using E. coli systems.

  3. The Potential Impact Of U.S. Tariffs On The Biotech Sector: Manufacturing, Funding, And Clinical Trials 5/12/2025

    Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.

  4. Advanced mAb Process Intensification Strategies 5/6/2025

    Advancements in perfusion media, high-density cell banking, and downstream intensification are streamlining biologics manufacturing for greater efficiency and cost-effectiveness.

  5. Optimize mAb Process Development To Reach Your Goals Quickly 5/6/2025

    In the pursuit of making your mAb process as efficient as possible, it is vital to identify the cell line, media, feed, and resin that best suit your productivity goals.

  6. Using Virtual Reality To Enhance Aseptic Contamination Control 5/1/2025

    Technologies such as virtual reality (VR), augmented reality (AR), or mixed reality can help alleviate some of the long-standing issues in aseptic contamination control. Here's how.

  7. Accelerated Tox Offerings: A Recipe For Streamlining IND Applications 4/22/2025

    Accelerating the timeline to tox material can significantly enhance the drug development process, enabling faster IND submissions and providing crucial time savings for toxicology studies.

  8. Increasing Biopharmaceutical Manufacturing Downstream Process Efficiencies 4/16/2025

    Downstream processing can account for up to 80% of biopharmaceutical production costs. Optimizing this stage is crucial for resource management, product quality, and overall yield.

  9. Top Safety Considerations In Biopharmaceutical Manufacturing 4/16/2025

    Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

  10. 9 Essential Oligosynthesis Component Needs 4/16/2025

    Meeting the growing need for oligonucleotides means having the right tools. Learn about the nine indispensable components, such as synthesis columns and C&D systems, for your facility.